LOGAN MENDHEIM: Open Payments
NPI 1871042226 · HELENA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 41 payments from 10 companies in 2025. Trend: 2023 $2,456 · 2024 $1,635 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $199 |
| ABBVIE INC. | 18 | $192 |
| Lundbeck LLC | 3 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
| Brainsway USA INC | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $13 |
Products named: Auvelity, VRAYLAR, REXULTI, CAPLYTA, SPRAVATO, TRINTELLIX, REJOYN, Deep TMS System.
Industry payments across AL — which companies pay providers there.
